Showing 31-40 of 3366 results for "".
Take 5 With Peter Kang, CEO, CoolHealth
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/take-5-with-peter-kang-ceo-coolhealth-1/23926/Physician Spotlight: Brett King, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-brett-king-md-phd/23321/Physician Spotlight: Bruce E. Strober MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-bruce-e-strober-md-phd/23010/Journal Club: Comparing Recommendations from Different AD Guidelines
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-comparing-recommendations-from-different-ad-guidelines/24466/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a pediatric dermatologist at Seattle Children's Hospital, about some of the differences in recommendations from the Annals of Allergy, Asthma, and Immunology Joint Task Force AD guidelines, and the Journal of the American Academy of Dermatology (JAAAtopic Dermatitis Journal Club: AD Guidelines May Represent a ‘Paradigm Shift’ in Care
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/atopic-derm-journal-club-ad-guidelines-may-represent-a-paradigm-shift-in-care/24075/In the first video of this series, Derek Chu, MD and Peter Lio, MD talk about new atopic dermatitis (AD) guidelines from the American Academy of Allergy, Asthma and Immunology Joint Task Force. These guidelines potentially represent a reshaping of the approach to AD care and understanding, accordingPhysician Spotlight: Alexander Egeberg, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-alexander-egeberg-md-phd/20976/How NEMLUVIO® Works
https://practicaldermatology.com/programs/nemluvio-peer-network/how-nemluvio-works/37226/Learn how NEMLUVIO® works to directly block IL-31RA from Dr Peter Lio, a leading dermatologist, with extensive experience in treating neuroimmune skin diseases.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/programs/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Physician Spotlight: Steven R. Feldman, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-4/23801/Benchside Dispatches Psoriasis
https://practicaldermatology.com/topics/psoriasis/benchside-dispatches-psoriasis/20922/An interview with Alice Gottlieb, MD, PhD